The Aortic Stent Graft Market refers to the global industry focused on the development, manufacturing, and distribution of stent graft devices used to treat aortic aneurysms and related vascular conditions. These minimally invasive devices reinforce weakened sections of the aorta, helping prevent life-threatening ruptures.
In 2025, the aortic stent graft market attained a value of USD 3.28 Billion. With rising cardiovascular disease prevalence and increasing adoption of minimally invasive procedures, the market is projected to grow at a CAGR of 5.80% between 2026 and 2035, reaching approximately USD 5.76 Billion by 2035.
The growing aging population, advancements in endovascular repair techniques, and improved patient outcomes compared to open surgery are key factors fueling market expansion.
How Large Is the Aortic Stent Graft Market and What Is the Forecast to 2035?
The Aortic Stent Graft Market is steadily expanding due to increased diagnosis of aortic aneurysms and improved screening programs. Abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA) cases are rising globally, especially among older adults and individuals with hypertension or atherosclerosis.
Key growth drivers include:
Increasing geriatric population
Rising incidence of cardiovascular diseases
Growing preference for endovascular aneurysm repair (EVAR and TEVAR)
Technological innovations in stent graft design
Expansion of specialized vascular centers
By 2035, demand for safer, flexible, and customized stent graft systems is expected to significantly influence market growth.
What Is an Aortic Stent Graft and How Does It Work?
An aortic stent graft is a tube composed of fabric supported by a metal mesh frame. It is delivered through a catheter inserted via the femoral artery and positioned inside the weakened section of the aorta. Once deployed, the graft reinforces the artery wall and redirects blood flow, reducing pressure on the aneurysm.
Compared to traditional open surgery, endovascular repair offers:
Shorter recovery time
Reduced hospital stay
Lower surgical risk
Less blood loss
Improved patient comfort
These advantages are contributing to the growing preference for stent graft procedures globally.
Market Breakup by Product
Abdominal Aortic Stent Graft
Abdominal aortic stent grafts account for the largest share of the Aortic Stent Graft Market. Abdominal aortic aneurysms are more common than thoracic aneurysms, particularly in elderly male populations. The widespread adoption of EVAR procedures is driving growth in this segment.
Thoracic Aortic Stent Graft
Thoracic aortic stent grafts are used in thoracic endovascular aneurysm repair (TEVAR). Although less common than AAA cases, thoracic aneurysms require complex device designs, contributing to higher per-unit costs and technological innovation.
Market Breakup by End User
Hospitals
Hospitals represent the largest end-user segment due to advanced surgical infrastructure and availability of vascular specialists. Complex aortic procedures typically require hospital-based facilities equipped with hybrid operating rooms.
Ambulatory Surgical Centers
Ambulatory surgical centers (ASCs) are gradually increasing their share, particularly for less complex endovascular procedures. Shorter recovery times make outpatient settings viable for selected patients.
Others
This segment includes specialty cardiac centers and research institutions involved in clinical trials and advanced vascular treatments.
What Regional Trends Are Shaping the Aortic Stent Graft Market?
North America
North America dominates the Aortic Stent Graft Market due to high cardiovascular disease prevalence, advanced healthcare infrastructure, and strong adoption of minimally invasive procedures. The United States leads in technological innovation and clinical research.
Europe
Europe holds a substantial market share supported by aging populations, universal healthcare systems, and established vascular surgery programs.
Asia Pacific
Asia Pacific is expected to experience the fastest growth during the forecast period. Rising healthcare investments, improving diagnostic capabilities, and growing awareness of cardiovascular diseases are key drivers in countries such as China, Japan, and India.
Latin America
Latin America shows moderate growth due to improving healthcare access and increasing cardiovascular screening initiatives.
Middle East and Africa
This region is witnessing gradual growth supported by expanding healthcare infrastructure and growing medical tourism.
Who Are the Leading Companies in the Aortic Stent Graft Market?
The Aortic Stent Graft Market is competitive, with major global medical device manufacturers focusing on innovation, regulatory approvals, and strategic partnerships.
Key companies include:
Cook Group Incorporated
W. L. Gore & Associates, Inc.
Medtronic
Terumo Corporation
Cordis
Artivion, Inc.
Endologix LLC
Lombard Medical
SB-KAWASUMI LABORATORIES, INC.
Endospan
LifeTech Scientific Corporation
Shanghai MicroPort Medical (Group) Co. Ltd.
Cardinal Health
Becton, Dickinson and Company
These companies are investing in next-generation stent graft systems with improved flexibility, durability, and anatomical compatibility.
What Technological Advancements Are Driving Market Growth?
Development of fenestrated and branched stent grafts
Improved imaging and navigation systems
Customizable graft designs for complex anatomies
Reduced-profile delivery systems
Enhanced biocompatible materials
Such innovations are increasing procedural success rates and expanding eligibility for high-risk patients.
What Challenges Does the Aortic Stent Graft Market Face?
Despite promising growth, several challenges remain:
High device costs
Risk of endoleaks and device migration
Complex regulatory approval processes
Limited access in low-income regions
Need for long-term follow-up and monitoring
Addressing these challenges through innovation and cost optimization will be critical for sustained market expansion.
FAQs
. What is the current size of the Aortic Stent Graft Market?
The Aortic Stent Graft Market was valued at USD 3.28 Billion in 2025 and is projected to reach USD 5.76 Billion by 2035, growing at a CAGR of 5.80%.
. What factors are driving growth in the Aortic Stent Graft Market?
The Aortic Stent Graft Market is driven by increasing aortic aneurysm cases, rising geriatric population, technological advancements, and growing preference for minimally invasive procedures.
. Which product segment dominates the market?
Abdominal aortic stent grafts dominate the market due to the higher prevalence of abdominal aortic aneurysms.
. Which region leads the market?
North America leads the market due to advanced healthcare systems and strong adoption of endovascular procedures.
. What are the key risks associated with stent graft procedures?
Risks include endoleaks, device migration, and need for long-term monitoring, though advancements continue to improve safety outcomes.
